BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28877722)

  • 1. Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancer.
    Gonnissen A; Isebaert S; Perneel C; McKee CM; Verrill C; Bryant RJ; Van Utterbeeck F; Lerut E; Haustermans K; Muschel RJ
    BMC Cancer; 2017 Sep; 17(1):634. PubMed ID: 28877722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.
    Gonnissen A; Isebaert S; Perneel C; McKee CM; Van Utterbeeck F; Lerut E; Verrill C; Bryant RJ; Joniau S; Muschel RJ; Haustermans K
    Am J Pathol; 2018 Mar; 188(3):795-804. PubMed ID: 29339090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression.
    Azoulay S; Terry S; Chimingqi M; Sirab N; Faucon H; Gil Diez de Medina S; Moutereau S; Maillé P; Soyeux P; Abbou C; Salomon L; Vacherot F; de La Taille A; Loric S; Allory Y
    J Pathol; 2008 Dec; 216(4):460-70. PubMed ID: 18825689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedgehog signaling protein expression and its association with prognostic parameters in prostate cancer: a retrospective study from the view point of new 2010 anatomic stage/prognostic groups.
    Kim TJ; Lee JY; Hwang TK; Kang CS; Choi YJ
    J Surg Oncol; 2011 Oct; 104(5):472-9. PubMed ID: 21656527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer.
    Yang Z; Peng YC; Gopalan A; Gao D; Chen Y; Joyner AL
    Dis Model Mech; 2017 Jan; 10(1):39-52. PubMed ID: 27935821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors.
    Lee SJ; Do IG; Lee J; Kim KM; Jang J; Sohn I; Kang WK
    Target Oncol; 2013 Dec; 8(4):271-80. PubMed ID: 23371028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer.
    Cao Z; Xu Y; Guo F; Chen X; Ji J; Xu H; He J; Yu Y; Sun Y; Lu X; Wang F
    Dis Markers; 2020; 2020():3904947. PubMed ID: 32655718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.
    Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy is related to the hedgehog signaling pathway in human gastric adenocarcinoma: prognostic significance of Beclin-1 and Gli2 expression in human gastric adenocarcinoma.
    Won KY; Kim GY; Lim SJ; Sung JY; Kim YW; Park YK; Lee J; Choi HS
    Pathol Res Pract; 2015 Apr; 211(4):308-15. PubMed ID: 25512258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
    Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
    Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death.
    Mortezavi A; Salemi S; Rupp NJ; Rüschoff JH; Hermanns T; Poyet C; Randazzo M; Simon HU; Moch H; Sulser T; Wild P; Eberli D
    Oncotarget; 2017 May; 8(19):31765-31774. PubMed ID: 28423666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.
    Benko G; Spajić B; Krušlin B; Tomas D
    Urol Oncol; 2013 May; 31(4):468-74. PubMed ID: 21514185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β
    Zhang M; Wang Q; Sun X; Yin Q; Chen J; Xu L; Xu C
    Prostate; 2020 Nov; 80(15):1328-1340. PubMed ID: 32894788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.
    Li N; Truong S; Nouri M; Moore J; Al Nakouzi N; Lubik AA; Buttyan R
    Oncogene; 2018 Apr; 37(17):2313-2325. PubMed ID: 29429990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome.
    He HC; Chen JH; Chen XB; Qin GQ; Cai C; Liang YX; Han ZD; Dai QS; Chen YR; Zeng GH; Zhu JG; Jiang FN; Zhong WD
    Pathol Oncol Res; 2012 Apr; 18(2):349-55. PubMed ID: 21861243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAGI-2 downregulation: a potential predictor of tumor progression and early recurrence in Han Chinese patients with prostate cancer.
    Cao Z; Ji J; Wang FB; Kong C; Xu H; Xu YL; Chen X; Yu YW; Sun YH
    Asian J Androl; 2020; 22(6):616-622. PubMed ID: 32167077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b.
    Karlou M; Lu JF; Wu G; Maity S; Tzelepi V; Navone NM; Hoang A; Logothetis CJ; Efstathiou E
    Prostate; 2012 Nov; 72(15):1638-47. PubMed ID: 22457212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive immunohistochemical analyses on expression levels of hedgehog signaling molecules in breast cancers.
    Kurebayashi J; Kanomata N; Koike Y; Ohta Y; Saitoh W; Kishino E
    Breast Cancer; 2018 Nov; 25(6):759-767. PubMed ID: 29946869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
    Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
    Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.